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Abstract
Acquired immunity to Plasmodium falciparum infection causes a change from frequent, sometimes life-threatening, malaria
in young children to asymptomatic, chronic infections in older children and adults. Little is known about how this transition
occurs but antibodies to the extremely diverse PfEMP1 parasite antigens are thought to play a role. PfEMP1 is encoded by a
family of 60 var genes that undergo clonal antigenic variation, potentially creating an antigenically heterogeneous infecting
population of parasites within the host. Previous theoretical work suggests that antibodies to PfEMP1 may play a role in
‘‘orchestrating’’ their expression within infections leading to sequential, homogeneous expression of var genes, and
prolonged infection chronicity. Here, using a cloning and sequencing approach we compare the var expression
homogeneity (VEH) between isolates from children with asymptomatic and clinical infections. We show that asymptomatic
infections have higher VEH than clinical infections and a broader host antibody response. We discuss this in relation to the
potential role of host antibodies in promoting chronicity of infection and parasite survival through the low transmission
season.
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Introduction
P. falciparum is a major cause of morbidity and mortality in sub-
Saharan Africa [1], mainly in children. This age distribution of the
disease burden can be attributed to the acquisition of immunity to
malaria following prolonged exposure to infections. Substantial
resistance to severe, life-threatening illness develops after relatively
few exposures to the parasite [2]. However, immunity to mild
malaria takes many years to develop and though older children
and adults rarely suffer clinical attacks, they remain susceptible to
chronic asymptomatic infections [3,4]. This non-sterilizing resis-
tance to disease suggests that naturally acquired immunity reflects
an altered host-parasite interaction. Here, we examined the
expression patterns of the large family of parasite molecules,
PfEMP1 (P. falciparum erythrocyte membrane protein 1), which are
thought to play a key role as targets of naturally acquired
immunity.
PfEMP1 are encoded by about 60 var genes per parasite genome
and expressed on the infected erythrocyte (IE) surface where they
mediate cytoadhesion of IE to host receptors such as ICAM1 and
CD36 [5,6]. Following an episode of malaria individuals develop
antibodies that are highly specific to the IE surface antigens
expressed by each individual infection [7–11], but which have the
potential to mediate variant-specific protection against future
disease [5,12–14]. In contrast, asymptomatic infections sampled
during the low malaria transmission season are associated with an
antibody response to a broad range of IE surface antigens when
compared to individuals sampled at the same time that do not
carry patent infections [15–18]. Notably, this association is evident
even after allowing for differences in exposure, suggesting that
these IE antibodies may be short-lived, broadly reactive responses
to the current infection [15,19]. Carriage of IE surface antibodies
among children with ongoing asymptomatic infections is associ-
ated with protection from future clinical malaria episodes [15–18].
Despite this apparent importance of antibodies, the details of
transition between clinical disease and asymptomatic infection are
still unclear.
Here, we used a cloning and sequencing approach to compare
the homogeneity of expression of var genes among parasites from
250 children with clinical and asymptomatic infections.
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Results
Published var gene expression profiles from 217 isolates from
children with clinical malaria and 33 with asymptomatic infection
were used for this study [20,21]. These were generated by
sequencing, classifying and counting samples of short sequence
tags amplified from the var DBLa domain region from parasite
cDNA libraries prepared from each isolate. Since most PfEMP1
contain a single DBLa domain, this region is suitable for var gene
expression profiling. Figure 1 summarizes the relative proportion
of different sequences sampled from each isolate. Visual inspection
of this data suggested that asymptomatic infections have more
homogeneous expression profiles. To analyse this further we
defined a measure of the homogeneity of the var expression profile
based on Simpson’s diversity index ([22], see Materials and
Methods).
Var Expression Homogeneity (VEH) is Associated with
Asymptomatic Infections
Figure 2A compares the VEH in parasites from children with
asymptomatic infections with those from children with clinical
infections, both severe and non-severe. Significant differences were
observed between asymptomatic and symptomatic infection
(Fig. 2A). Other characteristics of these children are also shown
in this figure. Figure 2B shows a measure of the breadth of their IE
surface antibody response measured against 8 isolates by
immunofluorescence [21] (see below). Children with asymptom-
atic infection had strikingly higher breadth of IE surface antibodies
using this assay (Fig. 2B). Asymptomatic children also had
significantly lower parasitaemia (Fig. 2C) and were older than
symptomatic children (Fig. 2D).
Since RNA was extracted from 100 ml of packed RBC from
each patient, the difference in VEH between asymptomatic and
clinical infections was unlikely to be simply due to sampling fewer
parasites from the asymptomatic children. However, to exclude
Figure 1. VEH and group A-like var expression levels among isolates from clinical and asymptomatic infections Presented are pie
charts summarizing the var expression profiles of all isolates from children with clinical malaria (grouped into severe and non-
severe malaria) and those with asymptomatic infection. Each slice of a pie chart (whether blue or green) represents a unique var sequence
with green representing group-A like var sequences. The size of the slice represents the percentage contribution of that sequence to the entire var
expression profile of the isolate. The pie charts are ordered from left to right by increasing VEH and top to bottom by increasing group-A like var
expression levels.
doi:10.1371/journal.pone.0070467.g001
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the possibility of a relationship between number of parasites
sampled and the observed VEH, serial parasite dilutions were
performed on a single lab-adapted isolate (3D7) into the range of
parasitaemia seen in asymptomatic infections. For each dilution,
we synthesized cDNA and generated var sequence tags. We then
assessed the relationship between the parasitaemia and VEH. If
high VEH was an artifact caused by sampling low numbers of
parasites from an isolate we would have expected VEH to be
highest where the parasitaemia was most diluted. However, we
found no evidence for this (Spearman’s rank correlation
rho=20.05, p = 0.9, Fig. S1A). To show that results were
consistent, sequencing of eight isolates from children with
asymptomatic infections was repeated using freshly synthesized
cDNA. Duplicate VEH scores were highly correlated (Spearman’s
rank correlation rho= 0.88, p = 0.004, Fig. S1B). Four of the
original var profiles from these isolates, 31E, 45B, 45E and 46B,
had clearly dominant sequences. The dominant sequences were
identical when the cDNA synthesis and sequencing were repeated.
We considered the possible influence of the number of
dominant parasite genotypes present in the infections on var
expression homogeneity. The number of dominant genotypes was
estimated by PCR amplification of MSP1 and GLURP genes
using non-nested primers to MSP1 and GLURP, followed by
visualization by gel electrophoresis. The maximum number of
bands observed between the two primer sets was recorded. A non-
nested approach was taken because, as with the var gene
Figure 2. Comparisons of VEH, IE surface antibody breadth, parasitaemia and host age. The Mann-Whitney U test is used to compare
asymptomatic and clinical infections in relation to VEH (A); heterologous IE surface antibody breadth measured as the median of the mean
fluorescence intensities measured against eight different parasite isolates as described previously [21] (B); parasitaemia (parasites6105/ ml blood, C);
host age (D). Blue arrows are used to indicate two individuals (46C and 46D) who became symptomatic with within the two days of sampling.
doi:10.1371/journal.pone.0070467.g002
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expression profiles, we were interested in the extent to which a
small number of genotypes dominated the infection at the time of
sampling rather than an estimate of the total number of genotypes
causing the infection. Though the number of dominant genotypes
showed an expected weak correlation with VEH (Spearman’s rank
correlation rho=20.14, p = 0.03), this was unlikely to be
important since the number of genotypes did not differ between
asymptomatic and clinical infections (Mann-Whitney U test,
p = 0.95, mean number of dominant genotypes for asymptomatic:
1.6 [95% CI,1.3–1.8]; non-severe: 1.6 [95% CI,1.5–1.8]; severe:
1.5 [95% CI,1.4–1.7]). Furthermore, the difference in VEH
between asymptomatic and clinical infections was evident even
when considering infections where a single genotype was observed
(Mann-Whitney U test, p,0.0001, comparing 18 asymptomatic
and 116 clinical infections).
In further support of a difference between asymptomatic and
clinical infections, two of the asymptomatic individuals (46C and
46D) attended hospital with clinical malaria within two days of
sampling (indicated with arrows in Fig. 2). Parasites from these two
individuals exhibited low VEH suggesting that diversification of var
expression may be a characteristic of within-host parasite
populations that are in the process of expanding.
The Role of Host Antibodies in Shaping the Infecting
Parasite Population
We and others have previously proposed that antibodies impose
a selection pressure on PfEMP1 molecules expressed by the
infecting parasite population such that only transcripts encoding
PfEMP1 variants to which the host lacks antibodies are expressed
[12,13]. Following from this we would predict that, in addition to
the previously described shift in expression away from the group of
var genes termed ‘‘group A-like’’ [21,23], a broad repertoire of IE
surface antibodies would be associated with more homogeneous
var expression profiles in the infecting parasite population.
Consistent with this prediction, the breadth of IE surface
antibodies, measured for each child by immunofluorescence
against 8 isolates [21], showed a positive correlation with VEH
(Fig. 3A). Despite an association between host age and IE surface
antibody breadth (Spearman’s rank correlation rho= 0.44,
p,0.0001), host age showed no association with VEH (Fig. 3B).
The association with antibodies may suggest that antibodies
play a role in determining the diversity of PfEMP1 expressed at
any one time during an infection. However, the antibody breadth
measure that we have used clearly does not explain all the
variation in VEH. This is made clear when asymptomatic and
symptomatic infections are viewed separately (Fig. 4A–C). Within
the asymptomatic infection and severe malaria groups there was
no evidence for a relationship between antibody breadth and VEH
(Fig. 4A,C). However a significant positive relationship between
antibody breadth and VEH was observed among parasites from
non-severe malaria cases (Fig. 4B). Though this is consistent with a
role for antibodies in shaping VEH, other host selection pressures
or features of the parasites or their expressed PfEMP1 may also be
influencing VEH within these groups of children. Since rosetting is
associated with high parasitaemia [21,24], we considered whether
this phenotype may enable parasites to out compete other variants
leading to higher VEH. However, there was no correlation
between the percentage of parasites that formed rosettes and VEH
(Spearman’s rank correlation rho= 0.06, p = 0.52, n = 133).
Since our measure of IE surface antibody breadth is against
eight parasite isolates, it only provides an estimate of the repertoire
of variant specific antibodies carried by each individual. It
provides no direct information on the ability of each individual
to recognize and control the variants expressed within their own
infection. Sufficient parasite material was available from 131
symptomatic children to explore the relationship between VEH
and the ‘‘homologous’’ antibodies induced to the infecting parasite
population. We tested each of the 131 parasite isolates against
each child’s homologous acute plasma sampled at the time of
disease (see Table S2). A weak positive association was observed
between the homologous IE surface antibody response and VEH
(Fig. 4D, Spearman’s rank correlation rho = 0.18, p = 0.04). This
experiment still has clear limitations because we do not have
information about recognition of other variants previously
expressed by the infecting parasite population other than those
expressed at the time of sampling. However, the results are
consistent with the idea that antibodies are involved in limiting the
diversity of PfEMP1 expressed by the parasite population. There
was no evidence that either homologous IE antibodies or IE
antibody breadth were associated with the number of dominant
genotypes present (Spearman’s rank correlation rho=20.0003,
p=1.00 and rho= 0.02, p=0.73 respectively).
An alternative interpretation is that some variants are efficient
at evading opsonization and maintaining cytoadherence even in
Figure 3. The relationship between VEH and host IE surface antibodies Scatter plots are shown of the relationship between VEH
and the breadth of the heterologous IE surface antibody response (A, see legend to figure 2); (B) shows the relationship between
VEH and host age. Spearman’s rank correlation coefficient rho was used to test for correlation.
doi:10.1371/journal.pone.0070467.g003
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the presence of a strong antibody response. Indeed recent
theoretical work has explained the evolution of a subset of long
var genes, such as those in group A, by predicting that they encode
PfEMP1 that are able to mediate cytoadherence with host
molecules and maintain sequestration and survival of parasites
even in the presence of host antibodies by engaging alternative
cytoadherence domains that are not recognized by the host [25]. It
was notable that among the 131 children with acute plasma
available, the child with the highest homologous antibody response
(27B) also had the highest VEH, which was mainly attributable to
a single group A-like var gene that constituted 98% of the var genes
expressed by the parasite isolate (Figure S2). Whilst no conclusive
interpretations can be made based on this data the hypothesis by
Buckee and Recker [25] warrants further study.
Discussion
Chronic asymptomatic infections are an essential part of the
parasite life cycle because they enhance parasite survival during
the dry seasons when the mosquito vector is absent and
transmission is low. However, the way in which parasites are able
to survive within the host for such long periods without exhausting
their variant antigen repertoire or causing clinical symptoms is
poorly understood. A possible explanation is that the host-parasite
interaction in chronic, asymptomatic infections is fundamentally
different from that in clinical malaria. This is supported by the fact
that asymptomatic infections sampled at a single time point at the
end of a period of low malaria transmission are associated with
lower parasite densities and broader IE surface antibody
repertoires when compared to clinical infections. Here, we further
show that isolates from children with asymptomatic infection have
more focused expression of var genes (higher VEH) than those
from children with clinical malaria. One weakness of this study is
Figure 4. The relationship between VEH and host IE surface antibodies to heterologous and homologous isolates. A-C show scatter
plots of the relationship between VEH and breadth of the heterologous IE surface antibody response as in Figure 3A, but split into asymptomatic (A),
non-severe (B) and severe malaria (C). (D) Shows the relationship between VEH and the homologous IE surface antibody response to each child’s own
parasites among children with malaria (measured as mean fluorescence intensity). Among children shown in (D), (E-F) compares the heterologous
and homologous responses among those with non-severe (E) and severe (F) malaria, respectively. The size of the marker in (E-F) is proportional to
VEH. Spearman’s rho was used to test for correlation.
doi:10.1371/journal.pone.0070467.g004
Plasmodium falciparum var Expression Homogeneity
PLOS ONE | www.plosone.org 5 July 2013 | Volume 8 | Issue 7 | e70467
that we sampled relatively few asymptomatic infections and only at
a single time point. Further studies are clearly needed to confirm
that our observations are generally true over the duration of
chronic infections.
We and others have previously shown that expression levels of
group A-like var genes are negatively associated with both host age
[20,26] and IE surface antibodies [20] [21]. We suggest that this
may be one of two ways in which naturally acquired immunity is
acquired (Fig. 5A). On the one hand, IE surface antibodies impose
a negative selection pressure on specific broad groups of
PfEMP1(Mode 1, Fig. 5A). The results presented here add
support to a second mode of immunity, in which the host is able to
limit the diversity of the PfEMP1 sequence types expressed by the
infecting parasite population (Mode 2, Fig. 5A). The results are
consistent with previous studies showing that antibodies impose a
variant specific selection pressure on variant surface antigens
expressed during disease [12] [13].
Much theoretical work has focused on the maintenance of
chronic asymptomatic infections through sequential antigenic
variation [27]. Two major problems arise when attempting to
explain sequential switching in P. falciparum. First, the repertoire of
PfEMP1 is relatively small. Second, the switch rate between
variants is high; 2% to 18% switch rates have been reported
[28,29]. It is therefore puzzling how chronic asymptomatic
infections are sustained without rapidly exhausting the genomic
PfEMP1 repertoire. Two recent theoretical models have suggested
the importance of non-variant specific antibodies in controlling
parasitaemia and limiting the rate of repertoire exhaustion. One
incorporates antibodies to non-PfEMP1 molecules but will still
only work if parasites have low switch rates [30]. Another is
compatible with higher switch rates and involves short-lived
antibody responses with a limited level of cross reactivity to minor
PfEMP1 epitopes coupled with long lived, variant specific
responses to major epitopes [19]. The effect of the partially
cross-reactive antibodies in this latter model is to restrict the
variants capable of dominating at any one time, equivalent to an
increase in VEH described here. Successive waves of variants are
those few that are recognized neither by long-lived responses to
major epitopes nor the current wave of cross-reactive responses to
minor epitopes. The efficiency of the responses to minor epitopes
was shown to correlate positively with the duration of the infection
and negatively with peak parasitaemia [19]. It is possible that
differences in the efficiency of responses to minor and major
epitopes exist between individuals with clinical and asymptomatic
infections. Alternatively, it may simply be necessary to build up a
threshold number of responses to minor epitopes before a chronic
infection can be maintained. Indeed, using the model previously
developed in [19] we found that VEH is predicted to rise in
relation to the number of responses accumulated to minor epitopes
(Figure 5B). If responses to minor epitopes lead to an increase in
the breadth of measured antibodies to several isolates, the
observed positive correlation within the theoretical model is
consistent with the data presented here, although there is clearly
considerable variation in VEH that cannot be explained solely by
this model (Figure 4A–C).
Parallel studies with laboratory isolates have raised the
possibility that parasites have partitioned their variant antigens
into those with low and high switch rates [31]. Modeling studies of
such parasites show that infecting parasite populations expressing
variants with different switching characteristics would potentially
lead to alternative paths within the network of possible switches.
Immune selection could lead to diversion from a path in which
many variants are expressed to one in which only small numbers
of variants are expressed. As suggested by Turner [32] in relation
to Trypanosoma brucei infections, rapid switching early in infection
would enhance competition between different genotypes, whilst
slower switch rates later in infection would extend infection length.
Such a model is compatible with studies of parasite infected
volunteers following mosquito-inoculation in which many parasite
variants dominate early in an infection, suggesting that the first
wave of parasites explore the available immunological space of the
host rather than committing to specific variants to which the host
may already have immunity to [33]. A recent study in Plasmodium
chabaudi also shows that parasites recently transmitted to mice by
mosquitoes express a much broader repertoire of cir variant
Figure 5. Modeling the relationship between VEH and host IE surface antibodies. In (A) we use pie charts to represent two modes in which
acquired immunity may modify the parasite population in a single host. In ‘‘mode 1’’ IE surface antibodies alter the relative abundance of parasites
expressing distinct PfEMP1 groups (pie chart slices, colours blue and green). In ‘‘mode 2’’ the acquired IE surface antibody repertoire is able to control
a wide range of PfEMP1 variants such that only a small number of variants dominate the PfEMP1 expression profile of the infecting parasite
population at any one time. Presented in (B) is an output from the mathematical model by Recker et al. This model was originally used to emphasize
how a combination of long-lived antibodies to unique major epitopes and transient antibodies to shared minor epitopes can limit the number of
synchronously expressed variants and prolong an infection [19]. Here, we replaced the duration of infection with a measure of the mean VEH of the
parasite population following runs of the model with different initial levels of antibodies to major and minor epitopes. The aim was to simulate
infections at different stages of their development. The graph shows the relationship between the initial number of each type of antibody [19] and
mean VEH. We speculate that the ability of the host to induce transient partially cross-reactive antibodies in the model is equivalent to the observed
breadth of IE surface antibody responses described in our dataset. Error bars represent the standard deviations.
doi:10.1371/journal.pone.0070467.g005
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antigen genes than parasites that have been serially passaged in
mice [34].
We have presented preliminary evidence supporting a model
that involves host immune selection, although further studies are
needed to fully establish the relative roles of host selection and
parasite control of var switching in explaining the variation in VEH
between isolates. Indeed, a study of parasites from The Gambia
[35] suggests an association between elevated PfSir2 expression
and severe malaria, which may involve a dysregulation of the
epigenetic control of var expression. This raises the possibility that
parasites may modulate their switching behavior in response to the
host or as part of a developmental programme.
Materials and Methods
Ethics Statement
Ethical approval for this study was granted by the Kenya
Medical Research Institute (KEMRI) Ethical Review Committee,
and written informed consent was obtained from the parents/
guardians of all study participants.
Study Site
The study was carried out at Kilifi District Hospital, situated at
the coast of Kenya. Ethical approval for this study was granted by
the Kenya Medical Research Institute Ethical Review Committee
and informed consent obtained from the parents/guardians of all
study participants.
Parasite Sampling
Details of the isolates from children with clinical malaria and
asymptomatic infections were published previously [20,21]. Of the
clinical cases severe malaria was defined as hospital admission with
impaired consciousness (Blantyre coma score ,4 in patients under
8 months old; ,5 in patients aged $8 months), severe malarial
anemia (hemoglobin ,5 g/dl), or respiratory distress (deep
‘‘Kussmaul’’ pattern of breathing). These were sampled between
August 2003 and September 2007. Peak malaria transmission in
Kilifi follows two rainy seasons in May to July and November to
December. Isolates from asymptomatic infections of any parasite
density were sampled during a cross-sectional survey just before
the start of the rainy season in May 2007 and are therefore most
likely to be from chronic infections that had been carried since the
last transmission season. These children have since been moni-
tored for episodes of malaria as part of an ongoing study.
Var Expression Profiling
For each child, expressed var sequences were generated from
ring-stage parasites as described previously [23] and are accessible
in the EMBL nucleotide sequence database (EMBL accession
numbers FN588437–FN592661; [20] for the symptomatic cases
and HE654181–HE654544 for the asymptomatic cases). Sequence
assembly, classification and counting were done using two
previously described analysis pipelines [20,36]. These analysis
pipelines were modified to calculate each isolate’s Simpson’s Index
of diversity as described below [22]. Expression frequencies of
each sequence tag are given in [21] for clinical cases and Table S1
for asymptomatic cases.
Parasite Genotyping
Parasite DNA was extracted either from whole EDTA treated
blood using a QIAamp DNA Blood Mini Kit (Qiagen) or obtained
as residual DNA in extracted RNA preparations using Trizol that
were performed on white cell depleted, heparinized blood as
described in ref [23]. MSP1 and GLURP genes were amplified as
described previously [37,38]. Bands were visualized using electro-
phoresis on 2% agarose gels.
Var Expression Homogeneity (VEH)
We defined VEH as the extent to which a small number of var
gene sequences dominate an isolate’s expression profile. In a
previous preliminary study we attempted to capture this using the
percentage of clones from each isolate that were among the most
dominant two sequences [23]. Here, to fully capture the
homogeneity of the var genes expressed by each isolate we
calculated the Simpson’s Index of diversity (l) [22], defined here as
the sum of the squares of the frequencies of each sequence type
represented in the var expression profile, (l~
P
N
i~1p
2
i , where pi
represents the proportion of a distinct var gene sequence i among
all N clones sampled from an isolate). The value of l thus ranges
between 1
N
, representing the least homogeneous var expression
profile (lowest VEH), and 1, representing the most homogeneous
var expression profile (highest VEH). This is the basic form of the
original Simpson’s diversity index, which does not take into
account the number of sequences sampled. We used this because
the number of sequences sampled per isolate was within a range
that was unlikely to influence the final calculation, which increases
when the number of sequences sampled per isolate is very low.
The mean number of sequences sampled per isolate was 68.0
(95% CI, 66.0–69.0). The number of sequences sampled in each
patient group was very similar, and if anything slightly higher in
the asymptomatic cases: asymptomatic, mean, 73.0 (95% CI,
69.3–76.6); non-severe, 67.6 (95% CI, 65.0–70.2); severe, 66.2
(95% CI, 63.5–68.9). See table S1 in ref. [21].
Assessment of Host IE Surface Antibodies
For each child’s plasma, flow cytometry was used to determine
IgG antibody levels against the infected erythrocyte surface of 8
clinical isolates. These heterologous IE antibody data are
published elsewhere [20,21]. For each child, the plasma used
was collected at the same time as the corresponding isolate used
for sequence analysis. To estimate each child’s IE surface antibody
breadth the median of each child’s responses to the 8 isolates
(acquired as mean fluorescence intensity, MFI) was used.
However, for three children with antibody data available for only
five of the 8 isolates the antibody breadth score was based on the
five isolates. Homologous IE antibodies were measured for a
subset of children’s plasma using the method described previously
[20,21] except plasma were tested against cultured parasites from
the same child. After sampling from the patient, parasites were
cultured until they matured to mid to late trophozoite stage and
stored frozen as described in [21].
Statistical Analysis
The statistical software StataTM version 11 was used for all the
analysis and p value ,0.05 considered significant for all tests.
Spearman’s rank correlation coefficient, rho was used to assess the
relationship between VEH and serial parasitaemia dilutions of a
single isolate (Fig. S1), host antibodies (Figs. 3–4) and host age
(Fig. 3B). The Mann-Whitney U test was used to compare clinical
and asymptomatic infections with respect to: IE surface antibody
breadth (Fig. 2B), host age (Fig. 2D), parasitaemia (Fig. 2C), VEH
(Fig. 2A) and multiplicity of infection (see text).
Mathematical model. We used the mathematical model
described by Recker et al. [19] to explore how orchestration of
antigenic variation might lead to an increase in the homogeneity of
var expression (VEH) by parasites sampled at a single time point.
In this model, which is described as a set of differential equations
Plasmodium falciparum var Expression Homogeneity
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in [19], transient, partially cross reactive antibodies are shown to
be capable of limiting the number of variants drawn at any one
time from a set of hypothetical variants. We investigated the
simulated relationship between parasite VEH and the host’s pre-
existing antibody repertoire generated by this model by randomly
assigning different numbers of cross-reactive responses to minor
epitopes or variant specific immune responses to major epitopes at
non-zero levels at the start of the infection (Fig. 5B). The model
uses 42 variant antigen molecules, each with a single unique
epitope and two minor epitopes 1 and 2. Minor epitope 1 had 6
variant forms and minor epitope 2 had 7 variant forms. As the
variant distribution during the initial peak is strongly dependent
on the initial conditions within this framework, we calculated an
average VEH over a fixed period of time instead (t = 200 arbitrary
units); this also takes into account the uncertainty about the onset
of infection in the data and is therefore better suited for qualitative
comparisons. VEH within this framework was then calculated as
s~ 1
N
P
t~1::N
P
i
yi(t)
Y (t)
 2
, where yi(t) is the frequency of variant i at
time t and Y(t) is the sum of all variants, i.e. Y (t)~
P
yi(t). The
model was run 200 times to obtain mean VEH scores and
standard deviations.
Supporting Information
Figure S1 Reproducibility of the VEH assay. A) Parasit-
aemia dilutions in a single isolate 3D7 are shown in relation to
VEH. The parasitaemia dilutions were done using freshly
prepared blood group O cells before synthesizing cDNA from
100 ml packed IE and generating var sequence tags. The
interquartile range of parasitaemias observed in the asymptomatic
patients was 0.1%–0.8% IE. B) repeat measures of VEH using
freshly prepared cDNA is compared with the original VEH
estimate. Repeat measures were generally lower because they were
calculated from raw sequence data from single reads for each
bacterial colony picked, whereas original VEH measures were
calculated from assembled sequence data which will tend to
collapse sequencing errors into fewer consensus sequences.
Spearman’s rank correlation coefficient and p values are indicated.
(TIF)
Figure S2 Heterologous and homologous IE surface
antibody response in relation to expression of group A-
like var genes. The heterologous and homologous responses are
compared as in Figure 4 (C-D). The size of each marker is
proportional to the expression levels of group A-like genes.
(TIF)
Table S1
(XLSX)
Table S2
(XLSX)
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